A carregar...
Impact of Immunotherapy after Resection of Pancreatic Cancer
BACKGROUND: Adjuvant immunotherapy has improved outcomes in patients with advanced melanoma; however, the potential benefit for patients with pancreatic ductal adenocarcinoma (PDAC) remains unknown. The aim of this study is to determine the impact of adjuvant chemotherapy and immunotherapy (CTx-IT)...
Na minha lista:
| Publicado no: | J Am Coll Surg |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599571/ https://ncbi.nlm.nih.gov/pubmed/30742911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2019.01.016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|